Clinical trial · Interventional
Oncologic Therapy Support Via Means of a Dedicated Mobile App
Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Oncologic Disorders | — | UNRESOLVED | — |
| Pelvic Neoplasm | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
| Radiotherapy; Complications | — | UNRESOLVED | — |
| Satisfaction | — | UNRESOLVED | — |
| Thoracic Neoplasm | Thoracic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| mobile application | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Mobile application
- description
- Patients undergoing radiotherapy will receive additional therapy support by an application installed on a mobile device
- interventionNames
- Other: mobile application
Primary outcomes (1)
- measure
- Feasibility judged by number of questions answered by each patient on each treatment day
- timeFrame
- 12-14 weeks
- description
- Feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day
Secondary outcomes (2)
- measure
- Treatment-related patient satisfaction
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Indication for radiotherapy with potentially curative intent of a primarily thoracic or pelvic target * Karnofsky performance score (KPS) ≥ 70%, * Ability to initiate the therapy as an outpatient * ≥ 18 years of age Exclusion Criteria: * Inability to give informed consent
References
Publications (1)
- DERIVEDEl Shafie RA, Bougatf N, Sprave T, Weber D, Oetzel D, Machmer T, Huber PE, Debus J, Nicolay NH. Oncologic Therapy Support Via Means of a Dedicated Mobile App (OPTIMISE-1): Protocol for a Prospective Pilot Trial. JMIR Res Protoc. 2018 Mar 6;7(3):e70. doi: 10.2196/resprot.8915. PMID 29510971